药品带量采购对患者医疗负担的政策效应研究  

Study on the Policy Effect of Drug Quantity Purchase on Patients’ Medical Burden

作　　者：李玉水[1] 康洽福 韩雅清 丁榕芳 LI Yu-shui;KANG Qia-fu;HAN Ya-qing;DING Rong-fang(College of Finance,Fujian Jiang Xia University,Fuzhou Fujian 350108,China)

机构地区：[1]福建江夏学院金融学院,福建福州350108 [2]中国铁路南昌局集团有限公司福州医疗保险事业管理中心,福建福州350013 [3]福建省社会医疗保险协会,福建福州350003

出　　处：《卫生经济研究》2021年第4期28-32,共5页

基　　金：福建省社会科学规划项目“健康中国战略背景下福建省医疗保障体系优化路径研究”(FJ2018B091)。

摘　　要：目的:评估"4+7"药品带量采购对降低患者医疗负担的政策效应。方法:使用福建省高血压、糖尿病患者省内异地就诊信息面板数据,采用双重差分方法进行实证分析。结果:实施药品带量采购政策后,高血压患者的总医疗费用负担下降了11.4%,其中药品费用负担下降了13.8%,非药品费用没有出现显著上涨,患者自付费用负担下降;政策对降低患者总医疗费用、药品费用的效应随时间的推进而提升,对降低不同等级医院就诊患者医疗负担的效应存在异质性。结论:在确保中选药品的可及性、使用中选药的约束力、加强非药品费用控制的前提下,实施药品带量采购政策可以有效降低患者医疗负担。Objective To evaluate the policy effect of"4+7"drug quantity purchase on reducing patients’medical burden.Methods Information panel data of medical treatment among patients with hypertension or diabetes in different place in Fujian province was collected and the double difference method was used for empirical analysis.Results after the implementation of the drug quantity purchase policy,the total medical cost burden of patients with hypertension decreased by 11.4%,of which the drug cost burden decreased by 13.8%,the non-drug cost did not increase significantly,and the out-of-pocket cost burden of patients decreased.The effect of the policy on reducing the total medical expenses and drug costs of patients increases over time,and there was heterogeneity in reducing the medical burden of patients in different levels of hospitals.Conclusion on the premise of the accessibility of selected drugs,the binding force of selected drugs in use,and strengthening the control of non-drug costs,the implementation of drug quantity purchase policy can effectively reduce the medical burden of patients.

关 键 词：药品带量采购 医疗负担 政策效应 双重差分 

分 类 号：R197[医药卫生—卫生事业管理]